Of the 11 cases of torsades de pointes listed in FDA's report, 6 involved psychiatric patients receiving high dosages of droperidol. Four cases involved droperidol doses of 2.5-25 mg; based on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback